Skip to content

Study · Non-randomized trial · n = 40 · 2007

4 results

[The effect of cerebrolysin on moderate cognitive impairment in cerebral vascular insufficiency (a clinical and electrophysiological study)].

Damulin IV, Koberskaia NN, Mkhitarian EA

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2007

PMID18379494 (opens in a new tab)PepBankPUB-18379494
Publisher pageAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with cerebral vascular insufficiency and moderate cognitive impairment, cerebrolysin reduced memory disturbances, with delayed effects observed 3 month after treatment.

    In plain wordsIn patients with cerebral vascular insufficiency and cognitive impairment, cerebrolysin reduced memory disturbances, with effects observed 3 month after treatment.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseMemory disturbances
    Study

    n = 40

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml per 200 ml of physiological solution · intravenous · 20 intravenous injections dailyAs given in this study (human).

    Source sentences

    Summary
    The course therapy with cerebrolysin reduced memory and attention disturbances improving the total cognitive status of patients.
    3 context sentences
    Summary · context
    The therapeutic effect had a delayed character being observed 3 month after completion of the treatment course.
    Summary · context
    The efficacy of cerebrolysin has been studied in 40 patients with cerebral vascular insufficiency and moderate cognitive impairment.
    Summary · context
    The treatment in dosage of 10 ml cerebrolysin per 200 ml of physiological solution (20 intravenous injections daily) was effective in this group of patients.
  2. 02HumanNon-randomized trialEfficacy outcome

    In patients with cerebral vascular insufficiency and moderate cognitive impairment, cerebrolysin reduced attention disturbances, with delayed effects observed 3 month after treatment.

    In plain wordsIn patients with cerebral vascular insufficiency and cognitive impairment, cerebrolysin reduced attention disturbances, with effects observed 3 month after treatment.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseAttention disturbances
    Study

    n = 40

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml per 200 ml of physiological solution · intravenous · 20 intravenous injections dailyAs given in this study (human).

    Source sentences

    Summary
    The course therapy with cerebrolysin reduced memory and attention disturbances improving the total cognitive status of patients.
    3 context sentences
    Summary · context
    The therapeutic effect had a delayed character being observed 3 month after completion of the treatment course.
    Summary · context
    The efficacy of cerebrolysin has been studied in 40 patients with cerebral vascular insufficiency and moderate cognitive impairment.
    Summary · context
    The treatment in dosage of 10 ml cerebrolysin per 200 ml of physiological solution (20 intravenous injections daily) was effective in this group of patients.
  3. 03HumanNon-randomized trialEfficacy outcome

    In patients with cerebral vascular insufficiency and moderate cognitive impairment, cerebrolysin improved total cognitive status, with delayed effects observed 3 month after treatment.

    In plain wordsIn patients with cerebral vascular insufficiency and cognitive impairment, cerebrolysin improved total cognitive status, with effects observed 3 month after treatment.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseTotal cognitive status
    Study

    n = 40

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml per 200 ml of physiological solution · intravenous · 20 intravenous injections dailyAs given in this study (human).

    Source sentences

    Summary
    The course therapy with cerebrolysin reduced memory and attention disturbances improving the total cognitive status of patients.
    3 context sentences
    Summary · context
    The therapeutic effect had a delayed character being observed 3 month after completion of the treatment course.
    Summary · context
    The efficacy of cerebrolysin has been studied in 40 patients with cerebral vascular insufficiency and moderate cognitive impairment.
    Summary · context
    The treatment in dosage of 10 ml cerebrolysin per 200 ml of physiological solution (20 intravenous injections daily) was effective in this group of patients.
  4. 04HumanNon-randomized trialEfficacy outcome

    In patients with vascular cognitive impairment, P300 electrophysiology confirmed clinical and neuropsychological observations after cerebrolysin treatment.

    In plain wordsIn patients with vascular cognitive impairment, electrical brain testing confirmed clinical observations after cerebrolysin treatment.

    Peptide
    Cerebrolysin
    Outcome
    Direction not reportedCognitive event-related potential P300 confirmation
    Study

    n = 40

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml per 200 ml of physiological solution · intravenous · 20 intravenous injections dailyAs given in this study (human).

    Source sentences

    Summary
    The data of clinical observations and neuropsychological testing have been confirmed by the results of electrophysiological study (cognitive event-related potential P300).
    2 context sentences
    Summary · context
    The efficacy of cerebrolysin has been studied in 40 patients with cerebral vascular insufficiency and moderate cognitive impairment.
    Summary · context
    The treatment in dosage of 10 ml cerebrolysin per 200 ml of physiological solution (20 intravenous injections daily) was effective in this group of patients.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.